Fear-Potentiated Startle Testing
Objective: Measure acoustic startle response amplitude enhancement in the presence of cues previously paired with shock (fear-potentiated startle) to examine neuroanatomical substrates of conditioned fear responses
This is a Fear-Potentiated Startle Testing protocol using rat as the model organism. The procedure involves 4 procedural steps, 4 equipment items, 2 materials. Extracted from a 1997 paper published in Journal of Neuroscience.
Model and subjects
rat • Not specified • Not specified • Not specified • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Fear conditioning with shock-paired cues • Intracranial drug infusion • Fear-potentiated startle testing
Primary readouts
- Acoustic startle response amplitude in presence of fear-conditioned cues
- Acoustic startle response amplitude in presence of bright light
- Comparison of startle enhancement between conditioned and unconditioned fear conditions
- Effects of AMPA receptor antagonist infusions on startle responses
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Fear conditioning with shock-paired cues
Rats are exposed to cues that are paired with electrical shock to establish conditioned fear associations
Note: This establishes the fear-eliciting stimulus for later testing
View evidence from paper
“in the presence of cues previously paired with shock (fear-potentiated startle)”
Intracranial drug infusion
Immediately before testing, rats receive intracranial infusions of either AMPA receptor antagonist (3 µg) or PBS vehicle control into target brain regions
Note: Infusions target basolateral nucleus of amygdala, central nucleus of amygdala, or bed nucleus of stria terminalis
View evidence from paper
“Immediately before light-enhanced or fear-potentiated startle testing, rats received intracranial infusions of the AMPA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulphamoylbenzo(F)-quinoxaline (3 µg) or PBS”
Fear-potentiated startle testing
Acoustic startle stimuli are presented in the presence of cues previously paired with shock, and startle response amplitude is measured
Note: Measures conditioned fear response; compared to light-enhanced startle (unconditioned response)
View evidence from paper
“The amplitude of the acoustic startle response is reliably enhanced when elicited in the presence of cues previously paired with shock (fear-potentiated startle)”
Light-enhanced startle testing
Acoustic startle stimuli are presented in the presence of bright light, and startle response amplitude is measured
Note: Measures unconditioned response to anxiogenic stimulus; compared to fear-potentiated startle
View evidence from paper
“The amplitude of the acoustic startle response is reliably enhanced when elicited in the presence of bright light (light-enhanced startle)”